SOBI — Swedish Orphan Biovitrum AB (publ) Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareBalancedLarge CapNeutral

Market Cap
SEK95.34bn
Enterprise Value
SEK110.94bn
Revenue
SEK26.03bn

Annual balance sheet for Swedish Orphan Biovitrum AB (publ), fiscal year end - December 31st, SEK millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	C2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	404	1,045	1,361	904	1,140
Net Total Accounts Receivable
Net Total Receivables	4,523	4,105	6,141	7,062	7,381
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	8,168	8,778	11,210	12,160	13,162
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	534	493	274	1,302	1,584
Net Goodwill
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	48,283	48,661	52,496	74,027	75,444
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	10,443	8,761	14,857	19,095	12,600
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Funded Status
Total Liabilities	28,077	25,458	25,971	40,160	35,158
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Unrealized Gain / Loss
Other Equity
Total Equity	20,206	23,203	26,525	33,867	40,286
Total Liabilities & Shareholders' Equity	48,283	48,661	52,496	74,027	75,444
Total Common Shares Outstanding